{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:57:45Z","timestamp":1790391465748,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Foundation for Overseas Scholars of Education Department of Heilongjiang Province","award":["1252HQ008"],"award-info":[{"award-number":["1252HQ008"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jpba.2017.01.008","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T19:47:41Z","timestamp":1484077661000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Quantification of hydroxyurea in human plasma by HPLC\u2013MS\/MS and its application to pharmacokinetics in patients with chronic myeloid leukaemia"],"prefix":"10.1016","volume":"137","author":[{"given":"Xin","family":"Hai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.01.008_bib0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0026-895X(25)09811-6","article-title":"Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2',3'-dideoxynucleosides","volume":"46","author":"Gao","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jpba.2017.01.008_bib0010","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V79.10.2555.2555","article-title":"Hydroxyurea effects on hemoglobin F production in patients with sickle cell anemia","volume":"79","author":"Charache","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2017.01.008_bib0015","first-page":"1685","article-title":"Pharmacokinetics of hydroxyurea 1000mg coated breakable tablets and 500mg capsules in pediatric and adult patients with sickle cell disease","volume":"91","author":"de Montalembert","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jpba.2017.01.008_bib0020","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2011-07-364190","article-title":"Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia","volume":"118","author":"Ware","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2017.01.008_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-6-30","article-title":"Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen","volume":"6","author":"Paule","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jpba.2017.01.008_bib0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-4347(98)00020-6","article-title":"New isocratic high-performance liquid chromatographic procedure to assay the anti-sickling compound hydroxyurea in plasma with ultraviolet detection","volume":"709","author":"Iyamu","year":"1998","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2017.01.008_bib0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-4347(97)00120-5","article-title":"Determination of hydroxyurea in plasma and peritoneal fluid by high-performance liquid chromatography using electrochemical detection","volume":"694","author":"Pujari","year":"1997","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2017.01.008_bib0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0378-4347(92)80586-F","article-title":"Determination by high-performance liquid chromatography of hydroxyurea in human plasma","volume":"584","author":"Havard","year":"1992","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2017.01.008_bib0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0003-2670(03)00702-5","article-title":"Analysis of hydroxyurea in human plasma by high performance liquid chromatography with electrochemical detection","volume":"488","author":"Jong","year":"2003","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2017.01.008_bib0050","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7064.1000244","article-title":"Development and validation of a liquid chromatography method with electrochemical detection for hydroxyurea quantification in human plasma and aqueous solutions","volume":"5","author":"Rodriguez","year":"2014","journal-title":"J. Chromatogr. Sep. Tech."},{"key":"10.1016\/j.jpba.2017.01.008_bib0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/03630260701587745","article-title":"Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell disease","volume":"31","author":"Bachir","year":"2007","journal-title":"Hemoglobin"},{"key":"10.1016\/j.jpba.2017.01.008_bib0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0378-4347(97)00634-8","article-title":"Colorimetric determination of hydroxyurea in human serum using high\u2013performance liquid chromatography","volume":"708","author":"Manouilov","year":"1998","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2017.01.008_bib0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2005.11.033","article-title":"Quantitative analysis of trimethylsilyl derivative of hydroxyurea in plasma by gas chromatography\u2013mass spectrometry","volume":"831","author":"James","year":"2006","journal-title":"J. Chromatogr B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.01.008_bib0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jchromb.2008.12.048","article-title":"Plasma hydroxyurea determined by gas chromatography\u2013mass spectrometry","volume":"877","author":"Kettani","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2017.01.008_bib0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-60761-459-3_26","article-title":"Determination of hydroxyurea in serum or plasma using gas chromatography-mass spectrometry (GC\u2013MS)","volume":"603","author":"Scott","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2017.01.008_bib0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/FTD.0000000000000145","article-title":"Isotope-dilution gas chromatography\u2013mass spectrometry method for the analysis of hydroxyurea","volume":"37","author":"Garg","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2017.01.008_bib0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2005.05583.x","article-title":"The measurement of urinary hydroxyurea in sickle cell anaemia","volume":"130","author":"Dalton","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jpba.2017.01.008_bib0090","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1373\/clinchem.2016.263715","article-title":"Stable-isotope dilution HPLC-electrospray ionization tandem mass spectrometry method for quantifying hydroxyurea in dried blood samples","volume":"62","author":"Marahatta","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2017.01.008_bib0095","series-title":"Bioanalytical Method Validation","article-title":"Guidance for industry","author":"Food and Drug Administration","year":"2013"},{"key":"10.1016\/j.jpba.2017.01.008_bib0100","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1365-2141.1996.d01-1733.x","article-title":"Evaluation of cytogenetic conversion to Ph- haemopoiesis in long-term bone marrow culture for patients with chronic myeloid leukaemia on conventional hydroxyurea therapy, on pulse high-dose hydroxyurea and on interferon-alpha","volume":"93","author":"Coutinho","year":"1996","journal-title":"Br. J. Haematol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851631113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851631113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T06:28:57Z","timestamp":1749882537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851631113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":20,"alternative-id":["S073170851631113X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.01.008","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of hydroxyurea in human plasma by HPLC\u2013MS\/MS and its application to pharmacokinetics in patients with chronic myeloid leukaemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}